Table II.
Sarcoma type | Histology | IHC | Cytogenetics |
---|---|---|---|
UPS | Cytological and nuclear pleomorphism | Positivity for antigens suggesting diverse lines of differentiation in the same tumor. | Great number of genetic alterations. Phenotypic spectrum of a single molecular entity with myxoid fibrosarcoma. |
SS | Biphasic: Spindle cell component with an epithelial component. Monophasic: Entirely compounded by the spindle component. | CK, EMA, S100, TLE1 positive. | Translocation t(X;18)(p11;q11) (90% of cases); fusion gene SSX-SYT. |
ES | Epithelial and spindle cells that form nodules. | Vimentin, CK, EMA positive. SMARCB/INI1 negative. | No conclusions about the genetic aberrations can be drawn due to the low incidence of this tumor. |
CCS | Spindle or polygonal cells with abundant cytoplasm disposed in nests with fibrous tracts between them. | Vimentin, HMB-45, S100, Melan-A positivity | Translocation t(12;22)(q13;q12); fusion gene EWS-ATF1. |
All data were obtained from reference (6). STS, soft tissue sarcomas; UPS, undifferentiated pleomorphic sarcoma; SS, synovial sarcoma; ES, epithelioid sarcoma; CCS, clear-cell sarcoma; IHC, immunohistochemistry.